Benitec Biopharma Inc. · NASDAQ:BNTC
Janus Henderson Group PLC reported a 11.40% stake in Benitec Biopharma Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 11.40% stake in Benitec Biopharma Inc., 2,918,950 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 11.40%
- Shares
- 2,918,950
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 11.40% | 2,918,950 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.60% | 2,193,481 |
Source
Related
- Benitec Biopharma Inc.
- Janus Henderson Group PLC
- Benitec Biopharma Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · Buchi J Kevin · Jun 30, 2026
- Schedule 13G/A · Franklin Resources Inc · Jan 29, 2026
- Schedule 13G · Ra Capital Management, L.P. · Dec 3, 2025
- Schedule 13D/A · Montanova Capital, LLC · Nov 10, 2025
- Schedule 13G/A · Franklin Resources Inc · Nov 4, 2025